American Healthcare REIT (AHR) EBITDA (2016 - 2026)

American Healthcare REIT (AHR) has reported EBITDA for 11 consecutive years, with -$435.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 27.21% year-over-year to -$435.8 million; the trailing twelve-month figure through Jun 2026 stood at -$1.6 billion (down 17.22% YoY), and the FY2025 full-year result was -$1.5 billion, down 7.32% from the prior year.
• EBITDA slipped to -$435.8 million in Q2 2026 per AHR's latest filing, from -$428.6 million in the prior quarter.
• Across five years, EBITDA topped out at -$173.1 million in Q4 2023 and bottomed at -$435.8 million in Q2 2026.
• Historically, EBITDA has averaged -$346.4 million across 5 years, with a median of -$348.6 million in 2024.
• The sharpest annual moves came in 2023 and 2024: EBITDA surged 51.89% in 2023, then tumbled 103.0% in 2024.
• Over 5 years, EBITDA stood at -$359.9 million in 2022, then soared by 51.89% to -$173.1 million in 2023, then sank by 103.0% to -$351.5 million in 2024, then dropped by 14.08% to -$401.0 million in 2025, then fell by 8.69% to -$435.8 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$435.8 million, -$428.6 million, and -$401.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.